Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

The Prognostic Significance of Carotid Intima-Media Thickness in Patients Who Underwent Percutaneous Coronary Intervention

  • Kwon, Taek-Geun (Cardiology Division, Heart Center, Konyang University Hospital) ;
  • Kim, Ki-Hong (Cardiology Division, Heart Center, Konyang University Hospital) ;
  • Yoon, Hyun-Ju (Cardiology Division, Heart Center, Konyang University Hospital) ;
  • Hyun, Dae-Woo (Cardiology Division, Heart Center, Konyang University Hospital) ;
  • Bae, Jang-Ho (Cardiology Division, Heart Center, Konyang University Hospital)
  • Published : 2007.03.30
⟨ Previous Next ⟩

Abstract

Background and Objectives：Increased carotid intima-media thickness (IMT) is known to be associated with adverse cardiovascular events in the patients with risk factors or established atherosclerosis. However, the prognostic importance of carotid IMT is uncertain in the patients who underwent percutaneous coronary intervention (PCI). We sought to evaluate the association of carotid IMT with major adverse cardiovascular events (MACE) and restenosis in the patients who underwent PCI. Subjects and Methods：The study population consisted of 308 consecutive patients who underwent PCI, and they were followed up for mean of 30.6±13.3 months. Base on the median values of carotid IMT, which was measured in the right common carotid artery at the time of PCI with using high-resolution ultrasound and a semiautomatic method, the subjects were divided into the thick (n=156, 1.003±0.14 mm) and thin IMT (n=152, 0.748±0.07 mm) groups, and they were followed up for at least 1 year. Results：Patients with thick carotid IMT were older (61±9 years vs. 57±10 years, respectively, p=0.001), had a higher body mass index (25.0±3.0 vs. 23.9±4.0, respectively, p=0.017), a history of previous myocardial infarction (20% vs. 9%, respectively, p=0.008), more multivessel disease and more restenosis (34.6% vs. 23.0%, respectively, p=0.025) than those patients with a thin carotid IMT. However other MACEs such as death, myocardial infarction, stroke, heart failure and target lesion revascularization did not show any significant differences between the two groups. Multivariate Cox regression analysis showed that carotid IMT was an independent predictor of restenosis (odds ratio: 1.754, 95% confidence interval: 1.1296 to 2.726, p=0.012). Conclusion：An increased carotid IMT is associated with restenosis, but it does not have clinical prognostic importance for the patients who underwent PCI during a mean follow up period of 31 months. (Korean Circulation J 2007;37:103-107)

Keywords

References

  1. Bae JH, Seung KB, Jung HO, et al. Analysis of Korean carotid intima-media thickness in Korean healthy subjects and patients with risk factors: Korea multi-center epidemiological study. Korean Circ J 2005;35:513-24 https://doi.org/10.4070/kcj.2005.35.7.513
  2. O'Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Stroke 1996;27:224-31 https://doi.org/10.1161/01.STR.27.2.224
  3. Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by highresolution ultrasonography and its relation to cardiovascular risk factors in the general popular of a Japanese city: the Suita study. Stroke 1997;28:518-25 https://doi.org/10.1161/01.STR.28.3.518
  4. Jeong IB, Kim KY, Bae JH, et al. The carotid intima-media thickness as a screening test for coronary artery disease. Korean Circ J 2005;35:460-6 https://doi.org/10.4070/kcj.2005.35.6.460
  5. Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middleaged adults: the Atherosclerosis Risk in Communities(ARIC) study. Stroke 1995;26:386-91 https://doi.org/10.1161/01.STR.26.3.386
  6. Crouse JR, Goldbourt U, Evans G , et al. Risk factors and segmentspecific carotid arterial enlargement in the Atherosclerosis Risk in Communities(ARIC) cohort. Stroke 1996;27:69-75 https://doi.org/10.1161/01.STR.27.1.69
  7. Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 1996;16:984-91 https://doi.org/10.1161/01.ATV.16.8.984
  8. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimalmedial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study.Circulation 2001;104:2815-9 https://doi.org/10.1161/hc4601.099486
  9. Park KR, Kim KY, Yoon SM, Bae JH, Seong IW. Correlation between intima-media thickness in carotid artery and the extent of coronary atherosclerosis. Korean Circ J 2003;33:401-8 https://doi.org/10.4070/kcj.2003.33.5.401
  10. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994;236:567-73 https://doi.org/10.1111/j.1365-2796.1994.tb00847.x
  11. Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 1997;28:1189-94 https://doi.org/10.1161/01.STR.28.6.1189
  12. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406 https://doi.org/10.1161/01.CIR.74.6.1399
  13. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22 https://doi.org/10.1056/NEJM199901073400103
  14. Kieltyka L, Urbina EM, Tang R, Bond MG , Srinivasan SR, Berenson GS. Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart Study. Atherosclerosis 2003;170:125-30 https://doi.org/10.1016/S0021-9150(03)00244-2
  15. Barth JD. Which tools are in your cardiac workshop?: carotid ultrasound, endothelial function, and magnetic resonance imaging. Am J Cardiol 2001;87:8A-14A
  16. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid intimamedia thickness in predicting clinical coronary event. Ann Intern Med 1998;128:262-9 https://doi.org/10.7326/0003-4819-128-4-199802150-00002
  17. Crouse JR 3rd, Byington RP, Bond MG , et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries(PLAC-II). Am J Cardiol 1995;75:455-9 https://doi.org/10.1016/S0002-9149(99)80580-3
  18. Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. Ann Intern Med 1996;124:548-56 https://doi.org/10.7326/0003-4819-124-6-199603150-00002
  19. McMahon S, Sharpe N, Gamble G , et al. Effects of lowering average or below average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. Circulation 1998;97:1784-90 https://doi.org/10.1161/01.CIR.97.18.1784
  20. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized clinical trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002;106:2055-60 https://doi.org/10.1161/01.CIR.0000034508.55617.65
  21. Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol(ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004;110:3512-7 https://doi.org/10.1161/01.CIR.0000148955.19792.8D
  22. Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000;102:1503-10 https://doi.org/10.1161/01.CIR.102.13.1503
  23. Rajagopal V, Rockson S. Coronary restenosis: a review of mechanisms and management. Am J Med 2003;115:547-53 https://doi.org/10.1016/S0002-9343(03)00477-7
  24. Buffon A, Liuzzo G , Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34:1512-21 https://doi.org/10.1016/S0735-1097(99)00348-4
  25. Hojo Y, Ikeda U, Katsuki T, et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000;84:83-7 https://doi.org/10.1136/heart.84.1.83
  26. Amar J, Fauvel J, Drouet L, et al. Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1. J Hypertens 2006;24:1083-8 https://doi.org/10.1097/01.hjh.0000226198.44181.0c
  27. Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis. Stroke 2006;37:351-7 https://doi.org/10.1161/01.STR.0000199034.26345.bc
  28. Elkind MS, Rundek T, Sciacca RR, et al. Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis 2005;180:181-7 https://doi.org/10.1016/j.atherosclerosis.2004.11.015